Zealthy vs Found
An in-depth comparison of two leading GLP-1 Providers
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Zealthy
Best for: coaching bundled into the price rather than sold separately
Visit Zealthy →
Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, Found opens cheaper — $149/mo against $286, and Found finishes ahead, 8.8 to 5.4. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.
Pricing
Zealthy
$151 medication + $135 monthly membership
$216 medication + $135 monthly membership
Found
$169/mo cash-pay on 12-month prepaid plan, medication+membership+coaching included; promo_price 99 = $99/mo WITH insurance (12-mo prepaid). Month-to-month: $199/mo insurance, $289/mo cash. Site-wide '$100 off today' checkout promo running.
Same single Compounded GLP-1 Plan price as semaglutide — no per-drug split published (final drug/price assignment is quiz-gated); $169/mo cash 12-mo prepaid ($289/mo month-to-month cash), $99/mo insurance prepaid.
'Starting cash price ~$149/mo' on /medication/foundayo comparison table; NEW offering since last verification.
Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.
Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.
Homepage carousel 'Ozempic® $1100/mo' — unchanged from prior verification.
Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.
What’s included
Zealthy
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Found
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Zealthy
5.4/10
Found
8.8/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Zealthy | Found |
|---|---|---|
| Starting Price | $286/mo | ✓$149/mo |
| Features | 3 features | 3 features |
| States Available | 34 | ✓50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | 2 warnings | ✓None |
About Zealthy
Active federal litigation and two FDA warning letters are disclosed in full; the entry exists here only for completeness, and the warnings and cons sections should be read before considering it. Zealthy sells compounded semaglutide and tirzepatide on an asynchronous telehealth model. FitRX, LLC is the legal entity, recently renamed Gronk Inc.
Read our full Zealthy review →About Found
Found is a personalized weight care platform. It runs on a self-pay membership, and medication costs sit on top of that.
Read our full Found review →Pros & Cons
Zealthy
What we like
- The monthly figure covers consult, shipping, coaching
Watch-outs
- No price appears until the medical intake is complete, so the cost cannot be compared before health information is submitted
- Coverage is published for 34 states only, so this may not reach you
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- 2 FDA warning letters matched to this operator in our enforcement register — read what the letter alleges, since a letter discloses a problem rather than disqualifying a seller
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Found
What we like
- Tirzepatide at $169 a month, 37% below the $267 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication, consult, coaching
- Coverage is published for all 50 states
- No FDA warning letter matched this operator when we searched our enforcement register
Watch-outs
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its orforglipron and semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Found takes it, 8.8 against 5.4, and it is especially strong on tirzepatide at $169/month, 37% under the register median. Zealthy is no weak second and may fit you better on coaching bundled into the price rather than sold separately.
Choose Zealthy if…
You want coaching bundled into the price rather than sold separately and an opening price near $286 a month.
Choose Found if…
You want tirzepatide at $169/month, 37% under the register median and an opening price near $149 a month.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Strut Health
Semaglutide at $99/month, 48% under the register median
From $99/mo
Get started →Oak
Semaglutide at $119/month, 37% under the register median
From $119/mo
Get started →Found
Tirzepatide at $169/month, 37% under the register median
From $99/mo
Get started →Zealthy vs Found: FAQ
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Zealthy and Found head-to-heads in the same category.
- Zealthy vs Trimi Health
- Zealthy vs Embody
- Zealthy vs He & She MD
- Found vs Lean Meds
- Found vs NextMeds
- Found vs bmiMD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.